Treatment of acute exacerbation of asthma
87 results
1 - 87
Treatment of acute exacerbation of asthma - Management of acute expiratory airflow obstruction and exacerbation of asthma in children
Ketamine for management of acute exacerbations of asthma in children- Diagnosis and treatment of childhood asthma
Two-day oral dexamethasone course effective in treatment of mild asthma exacerbation- Single-dose dexamethasone = 3 days of steroids in children with acute asthma
- More evidence against antibiotics for acute asthma exacerbations
- On-demand oral steroids minimally effective for childhood asthma
- No benefit to azithromycin for acute asthma exacerbations
- Respiratory failure
- Inhaled ipratropium bromide added to beta2-agonists for hospitalized children with acute asthma
- Corticosteroids for preventing relapse following acute exacerbations of asthma
- Corticosteroids for preventing relapse following acute exacerbations of asthma: Cochrane systematic review
- Inhaled anticholinergics and short-acting beta 2 -agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital: Cochrane systematic review
- Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
- Heliox for non‐intubated acute asthma patients
- Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children
- Combined inhaled anticholinergics and short-acting beta 2 -agonists for initial treatment of acute asthma in children: Cochrane systematic review
- 3 days equal to 5 days of oral steroids for acute asthma in children
- Dyspnoea
- Dexamethasone = prednisone for acute asthma in children
- Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department: Cochrane systematic review
- Continuous versus intermittent beta‐agonists for acute asthma
- Inhaled magnesium sulfate in the treatment of acute asthma
- Acute bronchitis
- Steroids better than montelukast in acute asthma exacerbations in children
- Anticholinergic therapy for acute asthma in children: Cochrane systematic review
- Education interventions for adults who attend the emergency room for acute asthma
- Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
- Difficulty breathing in a child
- Corticosteroids for hospitalised children with acute asthma
- Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
- Intravenous magnesium sulfate for treating children with acute asthma in the emergency department: Cochrane systematic review
- Antibiotics for exacerbations of asthma
- Written action plans for asthma in children
- Different oral corticosteroid regimens for acute asthma
- Exhaled nitric oxide levels to guide treatment for children with asthma
- Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma
- Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma
- Indigenous healthcare worker involvement for Indigenous adults and children with asthma
- Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews
- Prehospital emergency care
- Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma
- Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma
- Interventions for managing asthma in pregnancy: Cochrane systematic review
- Combination inhaled corticosteroids and long‐acting beta2‐agonists for children and adults with bronchiectasis
- Exhaled nitric oxide levels to guide treatment for adults with asthma
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
- Chronic obstructive pulmonary disease (COPD)
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
- Vilanterol and fluticasone furoate for asthma
- Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
- Supraventricular tachycardia (SVT)